Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 23
Phase 33

Trial Status

Recruiting4
Other2

Role Distribution

Principal Investigator6
PI Rate100%

Activity Timeline

Clinical Trials (6)

NCT06250972Phase 3Recruiting
Radiotherapy to Patients With CA19-9-elevated Advanced Pancreatic Cancer
Pancreatic Adenocarcinoma
PrincipalinvestigatorStart date: 2024-05-15
NCT06249321Phase 2Recruiting
mFOLFIRINOX Plus Radiotherapy to Patients With CA19-9-normal Advanced Pancreatic Cancer Refractory to Chemotherapy
Pancreatic CancerRadiotherapy
PrincipalinvestigatorStart date: 2024-04-01
NCT06149689Phase 2Recruiting
mFOLFIRINOX Plus Radiotherapy to Patients With CA19-9-normal Advanced Pancreatic Cancer
Pancreatic Adenocarcinoma
PrincipalinvestigatorStart date: 2024-01-10
NCT06017284Phase 3Recruiting
Thalidomide to Chemotherapy Related Nausea and Vomiting in Pancreatic Cancer
Chemotherapy-induced Nausea and VomitingPancreatic Cancer Stage IV
PrincipalinvestigatorStart date: 2023-11-01
NCT06018896Phase 2Unknown
Vitamin C to Quality of Life in Patients With Terminal Stage Pancreatic Cancer
Metastatic Pancreatic CancerTerminal Cancer
PrincipalinvestigatorStart date: 2023-08-25
NCT06018883Phase 3Unknown
Vitamin C to Chemotherapy Related Anemia in Pancreatic Cancer
Metastatic Pancreatic Adenocarcinoma
PrincipalinvestigatorStart date: 2023-08-20

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Publications (0)

No publications found for this investigator.

Clinical Trials (6)

Showing 6 of 6 trials

NCT06250972Phase 3PrincipalInvestigator

Radiotherapy to Patients With CA19-9-elevated Advanced Pancreatic Cancer

Pancreatic Adenocarcinoma
Recruiting
NCT06249321Phase 2PrincipalInvestigator

mFOLFIRINOX Plus Radiotherapy to Patients With CA19-9-normal Advanced Pancreatic Cancer Refractory to Chemotherapy

Pancreatic CancerRadiotherapy
Recruiting
NCT06149689Phase 2PrincipalInvestigator

mFOLFIRINOX Plus Radiotherapy to Patients With CA19-9-normal Advanced Pancreatic Cancer

Pancreatic Adenocarcinoma
Recruiting
NCT06017284Phase 3PrincipalInvestigator

Thalidomide to Chemotherapy Related Nausea and Vomiting in Pancreatic Cancer

Chemotherapy-induced Nausea and VomitingPancreatic Cancer Stage IV
Recruiting
NCT06018896Phase 2PrincipalInvestigator

Vitamin C to Quality of Life in Patients With Terminal Stage Pancreatic Cancer

Metastatic Pancreatic CancerTerminal Cancer
Unknown
NCT06018883Phase 3PrincipalInvestigator

Vitamin C to Chemotherapy Related Anemia in Pancreatic Cancer

Metastatic Pancreatic Adenocarcinoma
Unknown

All 6 trials loaded